RadNet (RDNT) Competitors

RadNet (NASDAQ:RDNT) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends and earnings.

Do insiders and institutionals hold more shares of RDNT or FMS?

77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer RDNT or FMS?

Fresenius Medical Care received 67 more outperform votes than RadNet when rated by MarketBeat users. However, 66.29% of users gave RadNet an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
RadNet	Outperform Votes 356 66.29%	Underperform Votes 181 33.71%
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%

Which has higher valuation and earnings, RDNT or FMS?

Fresenius Medical Care has higher revenue and earnings than RadNet. Fresenius Medical Care is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$1.83B	2.02	$3.04M	$0.03	1,664.30
Fresenius Medical Care	$19.34B	0.73	$540.07M	$0.99	24.25

Does the media refer more to RDNT or FMS?

In the previous week, RadNet had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 14 mentions for RadNet and 4 mentions for Fresenius Medical Care. RadNet's average media sentiment score of 1.04 beat Fresenius Medical Care's score of 1.03 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	8 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Fresenius Medical Care	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, RDNT or FMS?

RadNet has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500.

Is RDNT or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.25%	4.29%	1.45%
Fresenius Medical Care	3.43%	6.04%	2.69%

Do analysts rate RDNT or FMS?

RadNet currently has a consensus target price of $69.75, suggesting a potential upside of 39.70%. Fresenius Medical Care has a consensus target price of $25.30, suggesting a potential upside of 5.38%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.40
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

RadNet beats Fresenius Medical Care on 11 of the 19 factors compared between the two stocks.